• 1
    Banker, D.E., Groudine, M., Norwood, T, Appelbaum, F.R. (1997) Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia. Blood, 89, 243 255.
  • 2
    Bedi, A., Barber, J.P., Bedi, G.C., El-Deiry, W.S., Sidransky, D., Vala, M.S., Akhtar, A.J., Hilton, J, Jones, R.J. (1995) BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition following DNA damage: a mechanism of resistance to multiple anticancer agents. Blood, 86, 1148 1158.
  • 3
    Bedi, A., Zehnbauer, B.A., Barber, J.P., Sharkis, S.J, Jones, R.J. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood, 83, 2038 2044.
  • 4
    Boersma, A.W., Nooter, K., Oostrum, R.G, Stoter, G. (1996) Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin. Cytometry, 24, 123 130.
  • 5
    Campos, L., Fuyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D, Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473 476.
  • 6
    Campos, L., Rouault, J.-P., Sabido, O., Oriol, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J.-P, Guyotat, D. (1993) High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 81, 3091 3096.
  • 7
    Chabner, B.A & Myers, C.E. (1989) Clinical pharmacology of cancer chemotherapy. Cancer: Principles and Practice of Oncology (ed. by V. T. J. DeVita, S. Hellman and S. A. Rosenberg), p. 349. Lippincott, Philadelphia.
  • 8
    Chen, G., Shi, L., Litchfield, D.W, Greenberg, A.H. (1995) Rescue from granzyme B-induced apoptosis by Wee1 kinase. Journal of Experimental Medicine, 181, 2295 2300.
  • 9
    Clark, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L, Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature, 362, 849 852.
  • 10
    Collins, M.K.L., Marvel, J., Malde, P, Lopez-Rivas, A. (1992) Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. Journal of Experimental Medicine, 176, 1043 1051.
  • 11
    Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P, Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795 808.
  • 12
    Fuchs, E.J., Bedi, A., Jones, R.J, Hess, A.D. (1995) Cytotoxic T cells overcome BCR-ABL-mediated resistance to apoptosis. Cancer Research, 55, 463 466.
  • 13
    Gore, S.D., Donnenberg, A.D., Zehnbauer, B.A., Weng, L.J, Burke, P.J. (1994) Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery. Leukemia, 8, 409 419.
  • 14
    Gore, S.D., Weng, L.-J., Jones, R.J., Cowan, K., Zicha, M., Piantadosi, S, Burke, P.J. (1995) Impact of in vivo administration of interleukin-3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukaemia. Clinical Cancer Research, 1, 295 303.
  • 15
    Griffin, J.D & Lowenberg, B. (1986) Clonogenic cells in acute myeloblastic leukemia. Blood, 68, 1185 1195.
  • 16
    Joncourt, F., Oberli, A., Redmond, S.M.S., Fey, M.F., Tobler, A., Margison, G.P., Gratwohl, A., Buser, K, Cerny, T. (1993) Cytostatic drug resistance: parallel assessment of glutathione-based detoxifying enzymes, O6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemia . British Journal of Haematology, 85, 103 111.
  • 17
    Jones, R.J., Miller, C.B., Zehnbauer, B.A., Rowley, S.D., Colvin, O.M, Sensenbrenner, L.L. (1990) In vitro evaluation of combination drug purging for autologous bone marrow transplantation. Bone Marrow Transplantation, 5, 301 307.
  • 18
    Kaufmann, S.H., Karp, J.E., Jones, R.J., Miller, C.B., Schneider, E., Zwelling, L.A., Cowan, K., Wendel, K, Burke, P.J. (1994) Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood, 83, 517 530.
  • 19
    Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B, Jacks, T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847 849.
  • 20
    Lowenberg, B., Van Putten, W.L., Touw, I.P., Delwel, R, Santin, V. (1993) Autonomous proliferation of leukaemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. New England Journal of Medicine, 328, 614 619.
  • 21
    Maung, Z.T., MacLean, F.R., Reid, M.M., Pearson, A.D., Proctor, S.J., Hamilton, P.J, Hall, A.G. (1994) The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia. British Journal of Haematology, 88, 105 109.
  • 22
    McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K.M., Green, D.R, Cotter, T.G. (1994) R-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood, 83, 1179 1187.
  • 23
    Miller, C.B., Zehnbauer, B.A., Piantadosi, S., Rowley, S.D, Jones, R.J. (1991) Correlation of occult clonogenic leukemia drug sensitivity with relapse after autologous bone marrow transplantation. Blood, 78, 1125 1131.
  • 24
    Miyashita, T., Kitada, S., Krajewski, S., Horne, W.A., Delia, D, Reed, J.C. (1995) Overexpression of the Bcl-2 protein increases the half-life of p21Bax. Journal of Biological Chemistry, 270, 26049 26052.
  • 25
    Miyashita, T & Reed, J.C. (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood, 81, 151 157.
  • 26
    Nakajima, H., Golstein, P, Henkart, P.A. (1995) The target cell nucleus is not required for cell-mediated granzyme- or fas-based cytotoxicity. Journal of Experimental Medicine, 181, 1905 1909.
  • 27
    Norgaard, J.M., Langkjer, S.T., Palshof, T., Clausen, N., Pedersen, B, Hokland, P. (1996) Relation of blast cell survival and proliferation to chemotherapy resistance in AML. British Journal of Haematology, 93, 888 897.
  • 28
    Porwit-MacDonald, A., Ivory, K., Wilkinson, S., Wheatley, K., Wong, L, Janossy, G. (1995) Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia, 9, 1191 1198.
  • 29
    Prokocimer, M & Rotter, V. (1994) Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood, 84, 2391 2411.
  • 30
    Roger, R., Issaad, C., Pallardy, M., Leglise, M.-C., Turhan, A.G., Bertoglio, J, Breard, J. (1996) BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells. Blood, 87, 1113 1122.
  • 31
    Schulze-Osthoff, K., Walczak, H., Droge, W, Krammer, P.H. (1994) Cell nucleous and DNA fragmentation are not required for apoptosis. Journal of Cell Biology, 127, 15 20.
  • 32
    Sentman, C.L., Shutter, J.R., Hockenbery, D., Kanagawa, O, Korsmeyer, S.J. (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67, 879 888.
  • 33
    Shi, L., Nishioka, W.K., Thng, J., Bradbury, E.M., Litchfield, D.W, Greenberg, A.H. (1994) Premature p34cdc2 activation required for apoptosis. Science, 263, 1143 1145.
  • 34
    Steinmann, K.E., Belinsky, G.S., Lee, D, Schlegel, R. (1991) Chemically induced premature mitosis: differential response in rodent and human cells and the relationship to cyclin B synthesis and p34cdc2/cyclin B complex formation . Proceedings of the National Academy of Sciences of the United States of America, 88, 6843 6847.
  • 35
    Strasser, A., Harris, A.W, Cory, S. (1991) bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67, 889 899.
  • 36
    Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y, Hirai, H. (1992) Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood, 92, 2378 2383.
  • 37
    Tien, H.F., Wang, C.H., Chuang, S.M., Lee, F.Y., Liu, M.C., Chen, Y.C., Shen, M.C., Lin, D.T., Lin, K.H., Lin, K.S., Liu, C.H. (1992) Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis. Leukemia, 92, 907 914.
  • 38
    Van Engeland, M., Ramaekers, F.C., Schutte, B, Reutelingsperger, C.P. (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry, 24, 131 139.
  • 39
    Vaux, D.L., Aguila, H.L, Weissman, I.L. (1992) Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing. International Immunology, 4, 821 824.
  • 40
    Vermes, I., Haanen, C., Steffens-Nakken, H, Reutelingsperger, C. (1995) A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. Journal of Immunological Methods, 184, 39 51.